Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeWages, Salaries and Other
Others
Ratios

Avai Bio (AVAI) EPS (Basic) (2018 - 2024)

Avai Bio's EPS (Basic) history spans 4 years, with the latest figure at $0.01 for Q1 2024.

  • For Q1 2024, EPS (Basic) rose 167.21% year-over-year to $0.01; the TTM value through Mar 2024 reached -$0.03, down 231.04%, while the annual FY2025 figure was -$0.01, 50.0% up from the prior year.
  • EPS (Basic) for Q1 2024 was $0.01 at Avai Bio, up from -$0.03 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $0.02 in Q4 2020 and bottomed at -$0.03 in Q4 2023.
  • The 4-year median for EPS (Basic) is $0.0 (2020), against an average of -$0.0.
  • The largest annual shift saw EPS (Basic) plummeted 975.28% in 2023 before it soared 167.21% in 2024.
  • A 4-year view of EPS (Basic) shows it stood at $0.02 in 2020, then crashed by 78.41% to $0.0 in 2022, then tumbled by 975.28% to -$0.03 in 2023, then surged by 133.33% to $0.01 in 2024.
  • Per Business Quant, the three most recent readings for AVAI's EPS (Basic) are $0.01 (Q1 2024), -$0.03 (Q4 2023), and -$0.01 (Q3 2023).